人工智能驱动的胸部X线报告起草:2025年韩国胸部放射学会基于专家调查的立场声明
韩国胸部放射学会(KSTR)基于20名胸部放射科医师对60例胸片(覆盖健康筛查、住院、急诊、ICU、呼吸门诊和非呼吸门诊各10例)使用AI报告起草工具(KARA-CXR 1.0.0.3)的体验,开展两轮Delphi调查(12个关键问题共72项,9分Likert量表,共识需≥70%一致)。72项中41项(56.9%)达成共识;受访者对准确性和临床整合多持中性态度,仅对健康筛查场景持肯定看法;反对AI工具在常规实践中独立使用。KSTR支持仅在健康筛查场景且经放射科医师验证下使用AI自动起草胸片报告,反对常规独立使用,建议在采用前进行性能优化并制定学会认可的教育和指南。
要点
- KSTR支持AI自动起草胸片报告仅用于健康筛查场景,且必须经放射科医师验证。
- KSTR反对AI工具在常规实践中独立使用(stand-alone use)。
- Delphi调查72项中41项(56.9%)达成共识,受访者对准确性和临床整合多持中性态度。
- 仅健康筛查场景获肯定看法;常规实践独立使用遭反对。
- 建议在部署前进行性能优化,并制定学会认可的教育和指南后再采用。
适用人群与场景
- 健康筛查场景中使用AI自动起草胸片报告并由放射科医师验证。
- 不适用于常规实践中AI工具的独立使用。
研究设计与关键结果
- 研究类型为基于专家调查的立场声明,20名胸部放射科医师参与,使用60例胸片(健康筛查、住院、急诊、ICU、呼吸门诊、非呼吸门诊各10例)和AI报告起草工具(KARA-CXR 1.0.0.3),进行两轮Delphi调查。
- 12个关键问题共72项,9分Likert量表,共识需≥70%一致;41项(56.9%)达成共识。
- 受访者对准确性和临床整合多持中性态度;仅健康筛查场景获肯定看法;反对AI工具在常规实践中独立使用。
- 参与者强调部署前需进一步性能优化,并倡导在采用前制定学会认可的教育和指南。
证据类型、等级与局限
- 证据类型:专家调查(Delphi)为基础的学会立场声明。
- 共识标准:≥70%一致;72项中41项(56.9%)达成共识。
- 局限:原文未报告局限性
对床旁实践的改变
- KSTR支持仅在健康筛查场景且经放射科医师验证下使用AI自动起草胸片报告。
- KSTR反对AI工具在常规实践中独立使用。
- KSTR建议在采用前进行性能优化并制定学会认可的教育和指南。
指南或共识出处
- 韩国胸部放射学会(KSTR)2025年立场声明:Artificial Intelligence-Driven Drafting of Chest X-Ray Reports: 2025 Position Statement From the Korean Society of Thoracic Radiology Based on an Expert Survey(Korean J Radiol)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Generative artificial intelligence (AI) systems can be used to draft automated chest X-ray (CXR) reports. Although promising in terms of efficiency and workforce shortages, their accuracy, reliability, and clinical utility remain uncertain. This article presents the Korean Society of Thoracic Radiology (KSTR) position statement on AI-assisted CXR report drafting, derived from a Delphi survey of experts who used the software on a modest case set.
MATERIALS AND METHODS: Twenty thoracic radiologists completed a Delphi survey after reviewing 60 CXR cases using an AI-based tool for automated report drafting (KARA-CXR, version 1.0.0.3; KakaoBrain, Seoul, Republic of Korea). Prior to the Delphi survey, the participants individually reviewed 60 CXR cases at their respective workplaces as part of the survey preparation process. The 60 cases were distributed evenly across six clinical settings (health screening, inpatient, emergency department, intensive care unit, respiratory outpatient, and non-respiratory outpatient), with 10 cases in each setting. The participants individually selected CXR cases in which they had worked. The entire selection and review processes were completed within 1 month. Subsequently, two Delphi rounds were conducted. Participants rated 12 key questions (72 items) regarding the clinical applicability of the AI-based tool on a 9-point Likert scale. Consensus required ≥70% agreement.
RESULTS: Consensus emerged for 41 of 72 items (56.9%). Respondents adopted a neutral stance on most questions concerning accuracy and clinical integration; they were neither impressed nor disappointed with the tool. A favorable view emerged only for health-screening examinations. Conversely, the stand-alone use of the AI-based tool in routine practice was opposed. Participants stressed the need for further performance optimization before deployment and advocated society-endorsed education and guidelines before adoption.
CONCLUSION: The KSTR supports the use of an AI-based automated CXR report-drafting tool only in health-screening settings with radiologist validation and opposes its standalone use in routine practice, recommending performance optimization and society-endorsed education and guidelines before its adoption.
参考来源
- Jeong WG, Hwang EJ, Jin GY, et al. Artificial Intelligence-Driven Drafting of Chest X-Ray Reports: 2025 Position Statement From the Korean Society of Thoracic Radiology Based on an Expert Survey. Korean J Radiol. 2025. PMID: 41078017. doi:10.3348/kjr.2025.0457
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。